Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Dyspnea × Other × Clear all

Phase

Phase NA 28 Phase 2 12 Phase 2/3 3 Phase 3 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mucositis 8 Neoplasms 3 Head and Neck Neoplasms 3 Stomach Neoplasms 2 Lymphoma 2 Intestinal Obstruction 2 Gastrointestinal Stromal Tumors 2 Constipation 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Xerostomia 1 Stomatitis 1 Rectal Neoplasms 1 Radiation-induced Oral Mucositis 1 Pancreatic Neoplasms 1 Obesity 1 Nutrition Disorders 1 Neurotoxicity Syndromes 1 Motor Activity 1 Lymphoma, Large B-Cell, Diffuse 1 Hypertension 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Dyspnea 1 Diabetes Mellitus 1 Depression 1 Cardiovascular Diseases 1 Bile Duct Neoplasms 1

Interventions

Surveys and Questionnaires 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡